Embed Size (px)
DESCRIPTION
Citation preview
RPS Bylaws
RPS Application Form
Awards Bestowed by the RPS
Nephropathology Training Programs
RPS Officers
Presentations and Speakers at RPS Sponsored Scientific and Educational Sessions
The most important tool of the Communication and Publications Committee of the Renal Pathology Society is the RPS web-site. The objective of the site is to facilitate communication between the members of the RPS, and between the RPS other societies. To this effect, the web-site includes the directory of members with data regarding their areas of research interest - "yellow pages". Collaborative studies and surveys are posted, to ensure continuous availability. Visit the web-site at http://www.renalpathsoc.org/ and learn more about the history of the society, the upcoming international meetings or courses, the opportunities available, the composition of the committees. The Committee is pleased to have available two further services: upon request, electronic messages can be disseminated to all the members (contact [email protected]) and an electronic discussion group for renal pathology is available at NEPHNPT (contact [email protected]).
Suzanne Meleg-Smith, MDChair, Communication and Publications Committee
Information for Members
BYLAWS OF RENAL PATHOLOGY SOCIETY, INC(Incorporation version, 3/96, modified 11/97, 3/03, 4/04, 11/04)
Article IName:
Renal Pathology Society, Inc.Article II
Objectives:The objectives of the Society are to disseminate and to increase knowledge about the pathology and pathophysiology of the kidney, and to encourage the development of renal pathology as a subspecialty.
Article IIIMembership:A. Categories of Membership:
1. Regular Member Any holder of a MD, PhD, DVM, or equivalent degree with demonstrated interest and involvement in the field of renal pathology as determined by the Membership Committee using criteria agreed upon by the Board of Directors.
2. Emeritus Member A member over age 65 may become emeritus by requesting this status, in writing, to the Secretary-Treasurer.
3. Junior Member any holder of a MD, PhD, DVM, or equivalent degree with demonstrated interest in the field of renal pathology as evidenced by enrollment in a renal pathology training program or research at the resident or fellow level.
B. Membership Committee: Three members appointed by the President shall serve staggered terms of three years each. The Chair shall be the most senior member.
C. Conferring of Membership: An application form (designed by the Membership Committee and approved by the Board of Directors) must be sent to the Secretary-Treasurer. The Membership Committee will review the applications and recommend approval or disapproval by the Board of Directors. All members of the Renal Pathology Club shall automatically become Regular Members following approval of the Bylaws. However, to retain their Membership, these Charter Members must submit a Membership application form within 3 months after receiving the form from the Membership Committee. Membership can be terminated by written resignation addressed to the President or Secretary-Treasurer.
D. Rights of Members: Only Regular Members have the right to hold office and to vote. Each Regular Member has one vote. All Members have the right to attend the scientific sessions, and to participate in deliberations and discussions at the business meetings. No Member shall use the name, property, or the organization of the Society for personal benefit. Only currently elected officers shall represent the Society in official business.
E. New members will be approved continuously throughout the year as new applications are submitted to the Membership Committee for consideration. The chair and two members will decide whether the applicant can be approved as a member. Only in the case of questions or problems will the application be
delayed until those issues can be discussed at the business meeting. The membership will be notified at the next business meeting of the Society of all new members accepted and their corresponding affiliations.
Article IVOfficers:A. Elected Officers:
1. President Term of office is one year. If the President vacates the office prematurely, the Vice-President succeeds. A President may not succeed him/herself in office.
2. Vice-President/President-Elect Vice-President serves one year as Vice-President and shall succeed as President. If this office is vacated prematurely, the senior Councillor shall become Vice-President.
3. Secretary-Treasurer Term of office is three years, with a maximum of two terms. If this office is vacated prematurely, the President shall appoint a replacement to serve until the next election of officers.
4. Councillors Three councillors serve staggered terms of three years each. If this office is vacated prematurely, the President shall appoint a replacement to serve until the next election of officers.
B. Election of Officers:Any Society Regular Member is eligible to hold office. Nomination shall be recommended by a Nominating Committee and may be offered from the floor by any Regular Member. Election shall be by mail ballot. A majority vote of the responding members is required to elect an officer.
C. Duties of Each Officer:1. President The President shall be the principal
executive officer of the Society. He/she shall preside at all meetings, serve as Chair of the Board of Directors, and take responsibility as a representative of the Society. The President officially receives donations, bequests, or gifts to the Society on behalf of the Society. The President shall appoint all standing committees, and replacements for Vice-Presidents and Councillors who vacate their offices prematurely. Ad hoc committees shall be appointed by the President. Before finishing his/her term, the President shall select a councillor who must be approved by the membership by a majority vote. The Board of Directors may be called upon to make recommendations for the new councillor.
2. Vice-President The Vice-President, in absence or incapacity of the President, shall perform the duties of the President. Further, the Vice-President shall serve on the Board of Directors.
3. Secretary-Treasurer The Secretary-Treasurer shall keep minutes of the Annual and Board of Directors meetings, distribute notices to members of Society, keep custody of documents of Society (including mortgages, deeds, and contracts that the Board of Directors has approved), serve on the Board of Directors, receive membership applications and dues, keep records of financial documents for governmental agencies, banks or other financial institutions with approval of the President for expenses used solely for the Society. All such disbursements shall be reported at the Annual Meeting.
4. Compensation The Officers shall not be paid for their services and shall not receive any
financial benefits from their service as officers of the Society.
Article V Board of Directors:A. The Board of Directors shall consist of the current
officers (i.e., President, Vice-President, Secretary-Treasurer, and three Councillors), the past President, and Chairmen of the standing committees (i.e., the chairmen of the Auditing [Secretary-Treasurer], Program, Education and Scientific, Nominating and Awards, Membership, Training Programs, Communications and Publications, and Research Committees).
B. The Board of Directors shall:1. Represent the Society in official business.2. Carry out the directives and policies approved
by the membership.3. Organize and coordinate all meetings of the
Society, in collaboration with the Education and Scientific Meeting Committee.
4. Exert leadership in the development and implementation of scientific programs according to the above stated objectives of Society.
5. Deal specifically with matters related to the incorporation of Society.
Article VIStanding Committees (to be appointed by President):A. Program Committee The Committee shall be
responsible for the design, organization and conduct of the scientific meeting sponsored by the Renal Pathology Society at the United States-Canadian Academy of Pathology and American Society of Nephrology and shall report to the Board of Directors. The Committee shall be composed of no less than three members.
B. Education and Scientific Committee This Committee shall be responsible jointly with the Board of Directors for design, organization and conduct and other education efforts of the Society, and shall report to the Board of Directors. The Committee shall be composed of no less than three members.
C. Membership Committee (See Article III.)D. Nominating and Awards Committee This Committee
shall consist of three members. The past-President, acting as chair, and two additional acting Regular Members appointed by the current President. It shall be responsible for nominating new officers and selecting recipients for awards.
E. Training Programs Committee This Committee shall encourage broader availability of training opportunities in renal pathology and help to upgrade their quality. Committee activities shall include collection and dissemination of information about training programs and identification and development of sources of support for trainees.
F. Auditing Committee This Committee shall consist of three members. The Secretary-Treasurer, acting as chair, and two additional Regular Members appointed by the current president. It shall be responsible for an annual audit of Society financial affairs.
G. Communications and Publications Committee This Committee shall oversee development of and monitor the Society presence on online computer resources and print publications of the Society.
H. Research Committee This Committee shall plan and implement collaborative research projects involving the members of the RPS.
Article VIIMeetings:A. Scientific Meetings These meetings shall be held
twice annually during the annual American Society
of Nephrology Meeting, and U.S. and Canadian Academy of Pathology Meeting. The time and place will be determined by the Board of Directors.
B. Business Meeting This meeting shall be held annually during the ASN meeting. A quorum (i.e. 1/5 of total or 20 Regular Members) must be present to conduct business, but the scientific meeting may proceed in the absence of a quorum.
C. Board of Directors Meeting This meeting shall be held twice annually during the USCAP and ASN meetings.
D. Special Meetings These may be called as deemed necessary by the Board of Directors or President.
Article VIIIOrder of Business at the Annual Business Meeting:A. Determination of quorumB. Approval of the agendaC. Previous meeting minutes: Secretary-TreasurerD. Financial report: Secretary-TreasurerE. Reports of CommitteesF. Old businessG. New businessH. Announcement of new members and officersI. Adjournment
Article IXDues, Fees, and Compensation:A. Dues The annual dues shall be determined each year
by the Board of Directors.Junior members are not required to pay Society’s dues while in training.
B. Arrears Any member in arrears of dues for more than two years, failing satisfactory explanation, shall be dropped from membership. Such members may be reinstated on approval of the Membership Committee.
C. Compensation No Society officer shall receive compensation for his/her services as such. The Board of Directors, acting by majority vote, may authorize or ratify the payment to any officer or member of reasonable compensation for expenses incurred on behalf of the Society in any capacity deemed necessary or advisable and in the best interest of the Society.
Article XAmendments:Amendments to the Bylaws may be suggested in writing to the Secretary-Treasurer by any Regular Member at least two months prior to the Annual Business Meeting. If approved by the Board of Directors, this amendment needs to be accepted by a two-thirds majority mail vote of the Regular Members.
Article XILimitations and Dissolution:A. Limitations on Earnings No part of the net earnings
of the Society shall inure to the benefit of, or be distributable to its members, trustees, directors, officers, or other private persons except that the Society shall be authorized and empowered to pay reasonable compensation for services rendered and to make payments and distributions in furtherance of the Society's purposes as set forth in Article II.
B. Activities Not Permitted No substantial part of the activities of the Society shall be the carrying on of propaganda, or otherwise attempting to influence legislation, and the corporations shall not participate in or intervene in (including the publication or distribution of statements) of any political campaign on behalf of any candidate for public office. Notwithstanding any other provision of these bylaws, the corporation shall not carry on any other activity
not permitted to be carried on (a) by a corporation exempt from federal income tax under Section 501 (c) (3) of the Internal Revenue Code of 1986 (or the corresponding provision of any future United States Internal Revenue Law) or (b) by a corporation, contributions to which are a deductible under Section 170 (c) (2) of the Internal Revenue Code of 1986 (or the corresponding provision of any future United States Internal Revenue Law).
C. Dissolution Upon dissolution of the Society, the assets of the Society shall, after all its liabilities and obligations have been discharged or adequate provision made therefore, be distributed to the National Kidney Foundation if it is still in existence and is an exempt organization under Section 510 (c) (3) of the Internal Revenue Code or any successor section. If the National Kidney Foundation is not so qualified at the time of the dissolution of the corporation, the net assets shall be distributed to a corporation that is exempt under Section 501 (c) (3) of the Internal Revenue Code of 1986 or any successor section which is organized for purposes similar to those set out in Article II of these bylaws.
RENAL PATHOLOGY SOCIETY APPLICATION FORM
The Renal Pathology Society is a nonprofit organization committed to increasing and disseminating knowledge about the pathology and pathophysiology of the kidney. Membership is open to any MD, PhD, DVM, or equivalent degree holder who has demonstrated accomplishments in nephropathology as determined by the Membership Committee under the direction of the Executive Committee
Please type or print.
1. Membership requires fulfillment of at least one of the following criteria:Criterion 1: Publication of at least one peer-reviewed article in the field of nephropathology.Criterion 2: Completion of a minimum of six months research or clinical training in nephropathology,
e.g. during residency or postdoctoral fellowship.Criterion 3: Extensive clinical experience with the diagnostic pathologic evaluation of renal diseasesCriterion 4: Extensive research experience on the pathology, pathophysiology, or pathogenesis of
renal diseases.
Indicate by number which of these criteria you fulfill _______________
2. Fill in the following information:
Candidate Name
Position
Department
Institution
Street Address
City, State, Country, Mailing Code
Telephone FAX E-mail Address
I certify that the information supplied is correct, and hold the Renal Pathology Society and its members free from any damage or complaint resulting from any action they may take in connection with this application.
Signature of Applicant Date
Print name of RPS member Signature of RPS Member Datewho is sponsoring applicant.
3. Mail this form together with your current curriculum vitae to the Renal Pathology Society Chairman of the Membership Committee.
Renal Pathology Society Awards
YOUNG INVESTIGATOR AWARD
The Renal Pathology Society Young Investigator Award was established to recognize and encourage excellence in the area of renal pathology in accordance with the goals of the Society. The recipients of the award are selected from those nominated based on the contents of abstracts that they have submitted as first author to the annual meeting of the ASN or USCAP. The awards, in the amount of $500 (US), are presented at the ASN and USCAP Meetings.
Candidates must be nominated by a member of the Renal Pathology Society. The RPS member does not need to be a co-author of the submitted abstract but, if not, he or she should be from the same institution as the nominee. The research must have been carried out, while the candidate was a trainee (e.g., medical student, resident, fellow, graduate student) and not a faculty member.
Nominations should be submitted to the Chair of the Nominating and Award Committee.
Winners of the Renal Pathology Society Young Investigators Award
Awarded at the Recipient Title Sponsor
1995 USCAP Shane Meehan, M.D.Expression of TIA-1, a cytoxic I cell protein in renal allograft rejection.
R. B. Colvin
1996 USCAP Hugh B. Carey, M.D.
Early hypoxia induced loss of Na, K-ATpase polarity in proximal tubules is associated with specific calpain regulated fodrin processing.
M. Kashgarian
1996 ASN Tsuyoshi Oikawa, M.D.
Modulation of plasminogen activator inhibitor-1 (PAI-1) in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
A. Fogo
1997 USCAP Jorge Isaac, M.D.
In vitro AL-amyloid formation by human mesangial cells (HMCs) is attenuated by chloroquine
G. Herrera
1997 ASN Hitendra S. Jethwa
Variable region gene selection in murine anti-myeloperoxidase (MPO) autoantibodies
J.C. Jennette
1998 USCAP No award given
1999 USCAP Peter HeeringaExpression of chemokines in murine crescentic glomerulonephritis
J.C. Jennette
1999 ASN No award given
2000 USCAP Li-jun Ma
Regression of glomerulosclerosis in aging by angiotensin II Type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1)
A. Fogo
2000 ASN No award given
2001 ASN Michael Eikmans, Ph.D.
Blunted TGF-beta and ECM mRNA response during early acute rejection predicts for late development of chronic rejection
J. Bruijn
2003 USCAP Adrian Suarez, M.D.
Altered gene transcript profiles in congenitally obstructed human kidneys.
H. Liapis
2004 USCAP Hai-Chun Yang
Absence of integrin v6 decreases interstitial fibrosis but worsens glomerulosclerosis in remnant kidney mice
A. Fogo
2005 USCAP Xiubin Liang
Thymosin β4 is a marker or possibly even a contributor to glomerulosclerosis
A. Fogo
THE JACOB CHURG AWARDThe Jacob Churg Award, is presented annually at the USCAP meeting to an individual who has made major contributions to the field of nephropathology. The monetary component of the award is supported by a fund established by Barnert Hospital where Dr. Churg spent a substantial portion of his career on occasion of his retirement in 1996. Awardees are nominated by RPS members and selected from the nominations by the RPS Nominations and Awards Committee. Nominations, which should include a letter from the nominator and a C.V. of the nominee, should be sent to the Chair of this Committee.
The First Jacob Churg Award was presented to J. Charles Jennette, M.D. at the 1997 USCAP Meeting in Orlando, FLThe Second Jacob Churg Award was presented to Robert B. Colvin, M.D. at the 1998 USCAP Meeting in Boston, MA.The Third Jacob Churg Award was presented to Agnes Fogo, M.D. at the 1999 USCAP Meeting in San Francisco, CA.The Fourth Jacob Churg Award was presented to Vivette D’Agati, M.D. at the 2000 USCAP Meeting in New Orleans, LA.The Fifth Jacob Churg Award was presented to Melvin M. Schwartz, M.D. at the 2001 USCAP Meeting in Atlanta, GA.The Sixth Jacob Churg Award was presented to Fred Silva, M.D. at the 2002 USCAP Meeting in Chicago, IL. The Seventh Jacob Churg Award was presented to Charles Alpers, M.D. at the 2003 USCAP Meeting in Washington, DC.The Eighth Jacob Churg Award was presented to Michael Kashgarian, M.D. at the 2004 USCAP Meeting in Vancouver, Canada.The Ninth Jacob Churg Award was presented to Arthur Cohen, M.D. at the 2005 USCAP Meeting in San Antonio, TX.
Renal Pathology Fellowships and Program Directors
Program Site: Program Director: Mailing Address: Phone:FAX:
Brigham and Women's Hospital
Helmut G. Rennke, M.D. Department of PathologyBrigham & Women's Hospital75 Francis StreetBoston, MA 02115
Phone: (617) 732-6518FAX: (617) 227-9015
College of Physicians and Surgeons
Vivette D'Agati, M.D. Renal Pathology Laboratory VC14-219College of Physicians & Surgeons of Columbia University630 W 168th StreetNew York, NY 10032
Phone: (212) 305-6269FAX: (212) 305-5498
Cedars-Sinai Medical Center
Arthur H. Cohen, M.D. Department of PathologyCedars-Sinai Medical Center8700 Beverly BlvdLos Angeles, CA 90048
Phone: (310) 855-6621FAX: (310) 967-0122
Barnert Hospital, NJ
Surya Seshan, M.D. Department of PathologyBarnert Hospital680 BroadwayPaterson, NJ 07514
Phone: (201) 977-6770FAX: (201) 977-6812
University of Alberta
Kim Solez, M.D. Department of PathologyUniversity of Alberta5B4.02 Walter Mackenzie CentreEdmonton, AlbertaCanada T6G 2R7
Phone: (403) 492-2252FAX: (403) 492-2253
University of North Carolina at Chapel Hill
Volker Nickeleit, M.D Department of PathologyUniversity of North CarolinaSchool of MedicineChapel Hill, NC 27599-7525
Phone: (919) 966-2421FAX: (919) 966-4542
University of Washington
Charles E. Alpers, M.D. Division of Hospital PathologyUniversity of WashingtonMedical CenterRC72, Rm BB 210JSeattle, WA 98195
Phone: (206) 548-6409FAX: (206) 548-4928
Vanderbilt University
Agnes Fogo, M.D. Department of PathologyVanderbilt UniversityMedical Center, MCN C-331021st Avenue, SNashville, TN 37232
Phone: (615) 322-2102FAX: (615) 322-3988
Yale University Michael Kashgarian, M.D. Department of PathologyYale University School of MedicinePOB 208023New Haven, CT 0650-8023
Phone: (203) 785-275FAX: (203) 785-3348
Louisiana State University Health Sciences Center, Shreveport
Guillermo Herrera, M.D. Department of PathologyLSUHSC - Shreveport1501 Kings HighwayShreveport, LA 71130-3932
Phone: (318) 675-4557FAX: (318) 675-7662
Johns Hopkins Medical Institutions
Lorraine C. Racusen, M.D. Department of Pathology600 North Wolf StreetBaltimore, MD 21205
Phone: (410) 955-343FAX: (410) 614-9011
Members who have information about training programs not listed here are encouraged to contact the Chair of the Training Programs Committee.
RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS +
1993 1994 1995 1996 1997 1998Officers*:President: Gloria Gallo Michael Kashgarian Fred Silva Vivette D'Agati Arthur Cohen Robert ColvinVice-President: Michael Kashgarian Fred Silva Vivette D'Agati Arthur Cohen Robert Colvin Seymour RosenSecretary/Treasurer: Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles Jennette
Councillors: Arthur Cohen Arthur Cohen Arthur Cohen Robert Colvin Seymour Rosen Charles AlpersVivette D'Agati Vivette D'Agati Robert Colvin Seymour Rosen Charles Alpers Melvin SchwartzFred Silva Robert Colvin Seymour Rosen Charles Alpers Melvin Schwartz Agnes Fogo
Committees*:Membership: Samy Iskandar Regina Verani Agnes Fogo Stephen Bonsib Allan Katz Melvin Schwartz
Regina Verani Agnes Fogo Stephen Bonsib Allan Katz Melvin Schwartz Walter RichardsonAgnes Fogo Stephen Bonsib Allan Katz Melvin Schwartz Walter Richardson Alex Magil
Nominating Jay Bernstein Gloria Gallo Michael Kashgarian Fred Silva Vivette D'Agati Arthur Cohen & Awards: Benjamin Spargo Manjeri Venkatachalam Melvin Schwartz Surya Venkataseshan Seymour Rosen Mark Haas
Jean Olson Helmut Rennke Victoriano Pardo Mark Weiss Agnes Fogo Charles Alpers
Education Robert Colvin Charles Alpers Arthur Cohen Agnes Fogo Cynthia Nast Helmut Rennke & Scientific: Helmut Rennke Lorraine Racusen Vivette D'Agati Charles Alpers Michael Kashgarian Lorraine Racusen
Charles Alpers Mark Haas Jean Olson Helmut Rennke Lillian Gaber Seymour Rosen
Training Fred Silva Fred Silva Cynthia Nast Michael Kashgarian Guillermo Herrera Guillermo Herrera Programs: Gary Striker Gary Striker Helmut Rennke Liliane Striker Tibor Nadasdy Terry Oberley
Seymour Rosen Arthur Cohen Tibor Nadasdy Robert Colvin Regina Verani Volker Nickeleit
Auditing: Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles JennetteMark Weiss Gary Hill Guillermo Herrera Luan Truong Praveen Chander Jean OlsonCynthia Nast Agnes Fogo Dinyar Bhathena Dae Un Kim Isaac Stillman Anthony Nicastri
Communications & Cynthia Nast Cynthia Nast Samy Iskandar Samy Iskandar Publications: Kim Solez Kim Solez Kim Solez Kim Solez
Robert Colvin Gloria Gallo Charles Jennette Charles JennetteCharles Alpers Seymour Rosen optional Parmjeet RandhawaCharles Jennette Charles Jennette optional Stephen Bonsib
Research: Robert Colvin Cynthia NastByron Croker Byron CrokerMark Haas Tito Cavallo
*Board of Directors - officers and chairs of standing committees: Terms are for one year except for Secretary/Treasurer - 3 year term (limited to 2 terms), Councillors (3 year term) and Membership Committee (3 year term, staggered with senior member chair). Chair of the Nominating and Awards committee is the Past President. Chair of the Auditing Committee is the Secretary/Treasurer. Membership, Auditing and Nominating & Awards Committees are limited to 3 members. Education & Scientific Meeting Committees must have at least three members. Other committees are at discretion of the President. + Steering Committee of the Renal Pathology Club 1992. These are the members who oversaw the transition from club to society. Jay Bernstein, M.D., Frank A. Carone, M.D., Arthur H. Cohen, M.D., Robert B. Colvin, M.D., Ramzi Cotran, M.D., Vivette D'Agati, M.D., Gloria R. Gallo, M.D., Gary S. Hill, M.D., J. Charles Jennette, M.D., Michael Kashgarian, M.D., Vivian Pinn-Wiggins, M.D., H.G. Rennke, M.D., Seymour Rosen, M.D., Benjamin Spargo, M.D., Liliane M. Striker, M.D., M.A. Venkatachalam, M.D.
RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS +
1999 2000 2001 2002 2003 2004Officers*:
President: Seymour Rosen Charles Alpers Melvin Schwartz Agnes Fogo Cynthia Nast Charles JennetteVice-President: Charles Alpers Melvin Schwartz Agnes Fogo Cynthia Nast Charles Jennette Lorraine RacusenSecretary/Treasurer: Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera
Councillors: Melvin Schwartz Agnes Fogo Cynthia Nast Charles Jennette Lorraine Racusen Jan BruijnAgnes Fogo Cynthia Nast Charles Jennette Lorraine Racusen Helmet Rennke Steve Bonsib (2-year)Cynthia Nast Charles Jennette Lorraine Racusen Helmut Rennke Jan Bruijn Mark Haas (3-year)
Committees*:
Membership: Walter Richardson Alex Magil Alex Magil Patrick Walker Glen Markowitz Maria PickenAlex Magil Mark Weiss Mark Weiss Glen Markowitz Ian Roberts Ingeborg BajemaMark Weiss Suzanne Meleg-Smith Suzanne Meleg-Smith Maria Picken David Howell Zoltan Laszik
Nominating Robert Colvin Seymour Rosen Charles Alpers Melvin Schwartz Agnes Fogo Cynthia Nast & Awards: Charles Alpers Patrick Walker Steve Bonsib Steve Bonsib Jan Bruijn Vivette D’Agati
Michael Kashgarian Alex Magil Jan Bruijn Jan Bruijn Glen Markowitz Melvin Schwartz
Education Arthur Cohen Charles Jennette Tito Cavallo Jan Bruijn Jan Bruijn Steve Bonsib & Scientific: Guillermo Herrera Agnes Fogo Guillermo Herrera Finn Reinholt Mark Haas Laura Barisoni
Lorraine Racusen Melvin Schwartz Byron Croker Isaac Stillman Terry Cook Ian RobertsSeymour Rosen
Training Lorraine Racusen Lorraine Racusen Lorraine Racusen Lorraine Racusen Lorraine Racusen Agnes Fogo Programs: Tibor Nadasdy Michael Kashgarian Michael Kashgarian Mike Kashgarian Surya Seshan Samy Iskandar
Regina Verani Fred Silva Hermann-Josef Gröne Hermann-Josef Gröne Franco Ferrario Robert ColvinHermann-Josef Gröne
Auditing: Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo HerreraCharles Jennette Mary Ann Sens Mark Haas Carrie Phillips Joseph Zhou Randy HennigarJan Bruijn Maria Picken Surya Seshan Steve Bonsib Mary Fidler Sally SelfPaul Shanley
Communications Samy Iskandar Samy Iskandar Samy Iskandar Suzanne Meleg-Smith Suzanne Meleg-Smith Suzanne Meleg-Smith& Publications: Kim Solez Kim Solez Kim Solez Kim Solez Kim Solez Luiz Moura
Charles Jennette Helen Liapis Helen Liapis Helen Liapis Helen Liapis Kensuke Joh Parmjeet Randhawa Jan Bruijn Jan Bruijn Stephen Bonsib
Research: Cynthia Nast Cynthia Nast James Pullman James Pullman Patrick Walker Patrick WalkerFranco Ferrario Franco Ferrario Franco Ferrario Franco Ferrario James Pullman Terry Cook
James Pullman James Pullman Tibor Nadasdy Tibor Nadasdy Peter Furness Mark HaasRENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS
2003 2004
Program Committee Steve Bonsib Sharan Singh(begun in 2003) Helmut Rennke Surya Seshan
Laura Barisoni Volker Nickeleit Lois Arend Kenneth Bernstein
RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS
2005
President: Lorraine RacusenVice-President: Jan BruijnSecretary/Treasurer: Guillermo Herrera
Councillors: Steve BonsibMark Haas
Surya SeshanCommittees*:Membership: Maria Picken
Ingeborg BajemaZoltan Laszik
Nominating Charles Jennette& Awards: Michael Hughson
Arthur Abt
Education Ian Roberts & Scientific: Laura Barisoni
Steve Bonsib
Training Agnes FogoPrograms: Robert Colvin
Samy Iskandar
Research: Pat WalkerSerena BagnascoTerry CookMark HaasCarrie Phillips
Auditing: Luan TruongShamila MauiyyediRegina Verani
Communications Suzanne Meleg-Smith& Publications: Peter Furness
Kensuke JohLuiz MouraJean Olson
Program Committee Volker Nickeleit (begun in 2003) Charles Alpers
Jan Bruijn
Hermann-Josef Grone
Speakers and Topics of Renal Pathology Club Sponsored SessionsDate Moderator (s) Session Topic Speakers Titles
11/19/78 Michael Kashgarian, M.D. Idiopathic Nephrotic Syndrome With "Nil" Disease, Minimal Changes, Focal Segmental or Global Glomerulosclerosis
Jay Bernstein, M.D.
Michael Kashgarian, M.D.Peter Burkholder, M.D.Alfred Michael, M.D.
A Report from the International Study of Kidney Disease in ChildrenClinical-Pathologic CorrelationsEvidence for Immunologic MechanismsExperimental Models
11/18/79 Ramzi S. Cotran, M.D.Robert T. McCluskey, M.D.
Renee Habib, M.D. New Classification of Glomerulonephritis
Rapidly Progressive Glomerulonephritis William Couser, M.D.Curtis Wilson, M.D.
Robert Atkins, M.D.
Immunologic Spectrum of RPGNStudies on Anti-GBM Antibodies & Nephrotoxic AntigensMacrophages in Crescentic GN
11/23/80 Jacob Churg, M.D.Conrad L. Pirani, M.D.
The Kidney in Dysproteinemias Liliane Morel-Maroger, M.D.
Fred G. Silva, M.D.
Thomas Maack, M.D.
David Clyne, M.D.
The Pleomorphic Renal Pathology in "Myeloma" and Other DysproteinemiasUltrastructural Glomerular and Tubular Lesions in Plasma Cell DyscrasiasRenal Handling of Light Chain and Other Low Molecular Weight ProteinsExperimental Models of "Myeloma" Kidney
11/22/81 Ramzi S. Cotran, M.D.Robert H. Heptinstall, M.D.
Endothelium, Hemostasis and Intra-vascular Coagulation in the Kidney
Michael A. Gimbrone, Jr., M.D.Giuseppe Remuzzi, M.D.Jacob Churg, M.D.Robert H. Heptinstall, M.D.
Basic Biology of the EndotheliumRegulation of Platelet-Vessel Wall InteractionsCoagulation Processes in Renal GlomerulusRelations of Intravascular Coagulation and Endothelial Damage to Hypertension
12/12/82 Frank A. Carone, M.D. Renal Cystic Disease Jared Grantham, M.D.Frank A. Carone, M.D.
Andrew P. Evan, M.D.
Pathophysiology of Human Cystic DiseaseTubular Cell and Basement Membrane Changes in Experimental Cystic DiseaseEpithelial Hyperplasia in the Pathogenesis of Renal Cystic Disease
12/15/85 Benjamin H. Spargo, M.D. Pathology of Renal Transplantation Robert B. Colvin, M.D. Mechanisms of Graft Rejection: Phenotype and
Richard K. Sibley, M.D
Byron P. Croker, M.D., Ph.D.
Function of Infiltrating CellsRenal Allograft Histo- and Immunopathology in Cyclosporine Treated RecipientsGlomerulonephritis in Renal Allografts
12/7/86 Liliane J. Striker, M.D. Diabetic Kidney Disease Bryan Myers, M.D.
Peter Bennett, M.D.
Helmut Rennke, M.D.
Conrad Pirani, M.D.
Relationship Between Structure and Function in Human DiabetesEpidemiology of Diabetic Nephropathy in the Pima Indian PopulationNature of Progression of Glomerular Lesions in Diabetic Rats - Relationship with Human DiseaseThe Basement Membrane in Diabetic Nephropathy
12/13/87 Frank A. Carone, M.D. Current Concepts in the Pathogenesis of Polycystic Kidney Disease (PKD)
Frank A. Carone, M.D.Yashpal Kanwar, M.D., Ph.D.James McAteer, Ph.D.Kenneth D. Gardner, Jr., M.D.
Role of Epithelial Cell in PKDRole of Tubular Basement Membrane in PKDFactors Controlling Cyst GrowthEnvironmental Factors in PKD
12/11/88 Seymour Rosen, M.D. Vasculitis: Current Concepts Jacob Churg, M.D.J. Charles Jennette, M.D.
C.M. Lockwood, M.D.Ramzi S. Cotran, M.D.
Historical OverviewCrescentic Necrotizing Glomerulonephritis without Immune Complexes: An Expression of VasculitisAnti-Neutrophil Cytoplasmic AntibodiesPathogenesis of Vasculitis
12/3/89 Michael Kashgarian, M.D. Glomerular Mesangial Disease David H. Lovett, M.D.Steven Emancipator, M.D.Melvin M. Schwartz, M.D.Jean L. Olson, M.D.
Pathobiology of Glomerular MesangiumIgA NephropathyRole of Mesangium in Glomerular SclerosisHypertension and Glomerular Sclerosis
12/2/90 Jay Bernstein, M.D. Membranous Glomerulonephritis Revisited
Giuseppe Andres, M.D.Seymour Rosen, M.D.Richard J. Glassock, M.D.
Pathogenesis, an OverviewMorphologic EvolutionClinical Update
3/17/91 Michael Kashgarian, M.D.Fred Silva, M.D.
Current Topics in Renal Pathology J. Charles Jennette, M.D.Arthur Cohen, M.D.Robert Colvin, M.D.
Barbara Bane, M.D.
Anti-Neutrophil Cytoplasmic AutoantibodiesHIV and the KidneyRecent Advances in the Pathogenesis of Renal Allograft RejectionRenal Cell Carcinoma: Review and Update
11/17/91 Vivette D'Agati, M.D. Symposium on Cyclosporine Toxicity Michael Mihatsch, M.D.
Giuseppe Remuzzi, M.D.
Morphologic Features of Cyclosporine NephrotoxicityPathogenesis of Cyclosporine Nephrotoxicity
William Bennett, M.D. Clinical Update of Cyclosporine NephrotoxicityDate Moderator (s) Session Topic Speakers Titles3/15/92 Jay Bernstein, M.D. Current Topics in Renal Transplantation,
Tumors, Vascular Disease and Glomerulonephritis
Cynthia C. Nast, M.D.
J. Bruce Beckwith, M.D.Vivette D'Agati, M.D.Melvin M. Schwartz, M.D.
Renal Allograft Evaluation by Aspiration BiopsyWilm's Tumor and NephroblastomatosisHemolytic-Uremic SyndromeLupus Nephritis: The Results of the Lupus Collaborative Trial
11/15/92 Arthur Cohen, M.D. Focal Segmental Glomerulosclerosis Gary S. Hill, M.D.Agnes Fogo, M.D.Stephen Korbet, M.D.
Pathology of FSGSThe Pathogenesis of FSGSThe Clinical Management of FSGS
3/14/93 Melvin M. Schwartz, M.D. Current Topics in Glomerular Diseases and Transplantation
Gloria Gallo, M.D.Nancy L. Harris, M.D.Michael E. Lamm, M.D.Jay Bernstein, M.D.
Non-amyloid Fibrillary GlomerulopathiesPost-transplant Lymphoproliferative DisordersUpdate on IgA NephropathyGlomerulocystic Disease
11/14/93 Robert Colvin, M.D. Hemolytic-Uremic Syndrome Vivette D'Agati, M.D.Guiseppe Remuzzi, M.D.Michael Gimbrone, M.D.
Pathology and PathophysiologyClinical AspectsEndothelial Biology
3/13/94 Robert Colvin, M.D. Current Topics in Renal Pathology Nancy Harris, M.D.Kim Solez, M.D.
Robert McCluskey, M.D.Charles Alpers, M.D.
Post-transplant Lymphoproliferative DisorderPathology and Pathogenesis of Acute Tubular InjuryVasculitis: Pathology and PathogenesisCryoglobulinemia and Hepatitis C Virus
10/24/94 Charles Alpers, M.D. Familial Renal Disease Arthur Cohen, M.D.Billy Hudson, Ph.D.
Stephen Reeders, M.D.
The Renal Basement MembranopathiesType IV Collagen: Molecular Structure and Role in Glomerular DiseaseCloning of the Alport's and Polycystic Kidney Disease Genes: Clinical Aspects
3/12/95 Charles Alpers, M.D. Pathobiology of the Tubules and InterstitiumMichael Kashgarian, M.D.Alison A. Eddy, M.D.
Fred Silva, M.D.
Current Concepts in Acute Renal FailureMechanisms of Tubulointerstitial Injury and FibrosisTubular Cell Proliferation in Health and Disease
11/5/95 Vivette D'Agati, M.D. The Kidney in Hypertension Leopoldo Raij, M.D. Pathobiology of the Vascular Wall in Hypertension
Theodore Kurtz, M.D. New Genetic Models of Experimental Hypertension
Jean Olson, M.D. Renal Pathology of Hypertension: a Classical Date Moderator (s) Session Topic Speakers Titles
View Remodeled3/24/96 Arthur Cohen, M.D. Advanced Renal Disease and Renal
TransplantationMark Weiss, M.D.
Fred Sanfilippo, M.D.
Richard K. Sibley, M.D.
Stephen Bonsib, M.D.
Acquired Renal Cystic Disease and End-Stage KidneysCurrent Concepts in Transplant Immunology and PathobiologyPathology of the Transplanted Kidney: Update on Rejection and Classification SchemesRecurrent Diseases in the Transplanted Kidney
11/3/96 Agnes Fogo, M.D. Diabetic Nephropathy Kumar Sharma, M.D.Liliane Striker, M.D.Hans-Henrik Parving, M.D.
Mechanisms Underling Diabetic NephropathyRenal Pathology of DiabetesClinical Aspects of Diabetic Nephropathy
3/2/97 Agnes Fogo, M.D. New Approaches to Renal Biopsy Diagnosis and Prognosis
Cynthia Nast, M.D.
Richard E. Tracy, M.D.
Lorraine Racusen, M.D.Wayne Hancock, M.D.
Fine Needle Aspiration in Diagnosis of Renal DiseasesRenal Vasculopathies of Essential Hypertension - New Insights and ChallengesMolecular Markers in Acute Renal FailureNew Approaches in Renal Pathology: Transcriptional Factors, Functional Surface Molecules and Cytokine Products in Inflammatory and Immunologic Injuries
11/2/97 Cynthia C. Nast, M.D. Chronic Allograft Rejection Leendert C. Paul, M.D.Hallgrimur Benediktsson, M.D.Bertram L. Kasiske, M.D.
Pathogenetic ConsiderationsPathologic Features Clinical Aspects, Risk Factors, and Therapy
3/1/98 Cynthia C. Nast, M.D.Sylvana M. Tuur-Saunders
Viruses and the Kidney(Co-sponsor with Binford-Dammin Society)
Tibor Nadasdy, M.D.Sherif R. Zaki, M.D.Roger Smith, M.D.Marshall S. Horowitz, M.D.
Epstein-Barr VirusHemorrhagic DiseasesCMV and BK VirusAdenovirus Immunoregulatory Genes and Their Role in Islet-cell Transplantation, Autoimmunity and Viral Vector Design
10/25/98 Helmut Rennke, M.D. Advances in the Pathobiology of Acute Renal Failure
Richard Zager, M.D.
Seymour Rosen, M.D.Manjeri Venkatachalam, M.D.
The Multifactorial Nature of Acute Renal Failure: The Lessons Learnt from RhabdomyolysisModels of Acute Tubular Necrosis: A PerspectiveCell Biology and Molecular Mechanisms of Tubular Injury
3/21/99 Seymour Rosen, M.D. New Perspectives in Kidney Diseases John Eble, M.D. The Importance of the Classification of Renal
Vivette D’Agati, M.D.
Helmut G. Rennke, M.D.J. Charles Jennette, M.D.
NeoplasmsThe Nature of Nil Disease, Focal Glomerulosclerosis, and Collapsing GlomerulopathyThin Glomerular Basement Membrane DiseaseInsights into Systemic Vasculitis
11/6/99 Arthur Cohen, M.D. Antineutrophil Cytoplasmic Antibodies (ANCA) in Renal Disease: Is It Important Pathogenically or Is It an Epiphenomenon?
J. Charles Jennette, M.D.
Caroline O.S. Savage, M.D.John L. Niles, M.D.
Serologic and Pathologic Diseases of ANCA-Associated Renal DiseasesPathogenesis of ANCA-Related Renal InjuryUtility of ANCA in Long-Term Management and in the Transplant Setting
3/26/00 Arthur Cohen, M.D. Stephen A. Geller, M.D.
Disorders Affecting the Kidney and Liver Together
Wayne Grody, M.D.
Stephen A. Geller, M.D.Glen S. Markowitz, M.D.
The Genetics of Autosomal Dominant Polycystic Kidney DiseaseDuctal Plate Disorders of the LiverNew Animal Models of Autosomal Dominant Polycystic Kidney Disease
10/14/00 J. Charles Jennette, M.D. Surya Seshan, M.D.
Lupus Nephritis: Pathogenesis, Pathology, and Optimal Therapy
Michael Madaio, M.D.
Vivette D’Agati, M.D.
Edmund Lewis, M.D.
Pathogenesis of Lupus Nephritis: Therapeutic ImplicationsPathologic Characterization and Classification of Lupus NephritisClinical Management of Lupus Nephritis: Impact of Pathologic Findings
3/4/01 J. Charles Jennette, M.D. Advances in Renal Pathology and Pathophysiology
Gary Hill, M.D.Joseph P. Grande, M.D.
Helen Liapis, M.D.Andrey Shaw, M.D.
The Pathology of Lupus Nephritis: New InsightsOmega-3 Fatty Acids: Effects on the Pathogenesis and Progression of GlomerulonephritisMolecular Pathogenesis of Renal FibrosisNew Insights into Glomerular Podocyte Biology and Pathophysiology
10/14/01 Tito Cavallo, M.D. Mark Haas, M.D.
Renal AL-amyloidogenesis: New insights into Mechanisms and Therapy
Guillermo A. Herrera, M.D.
Raymond L. Comenzo, M.D.
Understanding the Pathogenesis of Renal AL-amyloidosisThe tropism of organ involvement in AL-amyloidosis
2/24/02 Tito Cavallo, M.D. Byron Croker, M.D.
Hereditary Nephropathies William L. Clapp, M.D.Billy G. Hudson, M.D.
Clifford E. Kashtan, M.D.
Paul S. Thorner, M.D.
Introduction to Hereditary NephropathiesMolecular Basis of Alport’s Syndrome: Organization, Assembly and Defects in Type IV CollagenAlport’s Syndrome and Thin Basement Membrane Nephropathy: Genes, Proteins and Clinico-pathologic CorrelationsAlport’s Syndrome: Prospect for Gene Therapy
11/4/02 William Couser, M.D. New Approaches in the Treatment of Andrew J. Rees, M.D. Macrophages in Renal Inflammation
Roger C. Wiggins, M.D. Crescentic Glomerulonephritis Raghu Kalluri, Ph.D.
Peter G. Tipping, M.D.
Charles D. Pusey, FRCP
Role of Novel Glomerular Basement Membrane Antigens in GlomerulonephritisCell-Mediated Aspects of Crescentic Glomerulonephritis: Contributions of Leukocytes and Intrinsic Renal CellsTherapies for Crescentic Glomerulonephritis
3/23/03 Stephen Bonsib, M.D. Tubulo-Interstitial Nephritis: Diagnostic Issues, Mechanisms, and Methodologies
John Tomaszewski, M.D.
Glen Markowitz, M.D.
Dr. Jeffery Kopp
Dr. Robert Star
Acute Interstitial Nephritis: Infection, Rejection, and AutoimmuneDrug-Induced Tubulointerstitial Nephropathies: New Insights and Old Concepts Tubular Epithelial Cell Injury and Interstitial FibrosisNew Methods to Diagnose Kidney Disease: Lasers, Chips, & Dendrimers and Beyond
11/15/03 Stephen Bonsib, M.D. Surya Seshan, M.D.
An SLE Update: Clinicopathologic Correlations
J. Charles Jennette, M.D.
Lee A. Hebert, M.D.
Howard A. Austin, M.D.
New Concepts in the Classification of SLE Nephritis: Pathological AspectsClinical Implications from the Reclassification of the Kidney Biopsy in SLESLE Nephritis in Different Clinical Populations: Therapeutic and Prognostic Considerations
3/7/04 Sharan K. Singh, M.D. Update on Renal Transplant Pathology Volker Nickeleit, M.D.
Robert B. Colvin, M.D.
Lorraine C. Racusen, M.D.
Neeraja Kambham, M.D.
The Importance of Routinely Evaluating C4d in Renal Allograft Biopsy SpecimensNew Insights on Chronic Allograft Nephropathy/Chronic RejectionPractical Update on the Pathologic Classification of Renal Transplant Pathology Including Criteria for Antibody Mediated RejectionGene Microarray Analysis of Acute Renal Allograft Rejection
10/29/04 Robert B. Colvin, M.D. Harsharan K. Singh, M.D.
Donor Pretreatment and Protocol Biopsies of Kidney Allografts: A Critical Update
Lorraine C. Racusen, M.D.Volker Nickeleit, M.D., Ph.D.David N. Rush, M.D.
Alan H. Wilkinson, M.D.
New Markers of RejectionBaseline (Zero Hour) BiopsiesProtocol Biopsies and Follow-up Biopsies: A Debate – ProProtocol Biopsies and Follow-up Biopsies: A Debate – Con
2/27/05 Luan D. Truong, M.D. Pathobiology of the Podocyte Peter Mundel, M.D.
Vivette D’Agati, M.D.
Laura Barisoni, M.D.
Novel Insight Into the Pathogenesis of Nephrotic SyndromePrimary and Secondary Focal Segmental Glomerulosclerosis: Morphologic Classification and Clinical CorrelationModulation of Podocyte Phenotype and the Emerging Role of Biomarkers in Podocytopathies
Agnes B. Fogo, M.D. Progression and Potential Regression of Glomerulosclerosis
